Back | Next |
home / stock / tltff / tltff message board
Subject | By | Source | When |
---|---|---|---|
This stockhouse poster has a + view and | -3 | investorshub | 09/04/2022 7:06:32 PM |
Looks a bit like TLT ?????????? | -3 | investorshub | 09/03/2022 3:06:22 PM |
Quarterly Update.. | MeghanStar | investorshub | 09/01/2022 3:36:30 PM |
Anyone read Jessie Stine's book ? | -3 | investorshub | 08/21/2022 8:10:07 PM |
Egon. post at 4126 answers those ? of | -3 | investorshub | 08/19/2022 1:10:54 PM |
The board needs the opinion of a knowing | -3 | investorshub | 07/07/2022 7:32:25 PM |
94.4 % kill of cancer out of 38 | -3 | investorshub | 07/01/2022 4:33:16 PM |
Looking good Thanks BigK | SPORT19 | investorshub | 06/13/2022 8:37:25 PM |
Informed poster https://stockhouse.com/companies/bullboard/v.tlt/theralase-te | -3 | investorshub | 06/13/2022 10:09:48 AM |
Total Evaluable Patients - Great Updates | BIGKAHUNA57 | investorshub | 05/08/2022 4:48:20 PM |
To have a Complete Response 53 % | -3 | investorshub | 05/04/2022 11:44:30 AM |
We are close to a breakaway . | -3 | investorshub | 05/03/2022 12:46:55 PM |
Eogan. tells us what TLT has achieved and | -3 | investorshub | 04/27/2022 1:00:46 PM |
Warrants will not be paid move ? Warrants | -3 | investorshub | 04/25/2022 5:57:57 PM |
Might be the simplest/clearest understanding of the treatment | -3 | investorshub | 04/25/2022 12:39:22 PM |
This is an interpretation of data that is | -3 | investorshub | 04/19/2022 10:00:46 AM |
Is this the explanation ? https://stockhouse.com/companies/bullboard/v.tlt/ther | -3 | investorshub | 04/15/2022 10:34:11 PM |
Here is a criticism that to me is | -3 | investorshub | 04/15/2022 8:09:34 PM |
$TLTFF - receives a target raise from Research | 123414 | investorshub | 04/11/2022 2:37:14 PM |
Thnks ! | -3 | investorshub | 04/10/2022 12:46:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Theralase Technologies Inc. Company Name:
TLTFF Stock Symbol:
OTCMKTS Market:
Theralase Technologies Inc. Website:
TORONTO, ON / ACCESSWIRE / May 2, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs "...
TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase ® Technologies Inc. (" Theralase ® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF )( FRA:TTX ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic C...
TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs...